Funded Tech Companies

BioVersys

BioVersys, based in Basel, has financial backing through AMR Action Fund.

Company Overview

Company Name
BioVersys
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
c/o Technologiepark Hochbergerstrasse 60c
Basel, CH-4057
CH
Email Address

Company Background Information

Overview
BioVersys AG is a privately-owned clinical stage Swiss pharmaceutical company focusing on research and development of small molecules acting on novel bacterial targets with applications in antimicrobial resistance (AMR) and targeted microbiome modulation. With the company's award-winning TRIC technology we can overcome resistance mechanisms, block virulence production and directly affect the pathogenesis of harmful bacteria, towards the identification of new treatment options in the antimicrobial and microbiome fields.
Profile
BioVersys LinkedIn Company Profile
Social Media
BioVersys Company Twitter Account
Company News
BioVersys News
Facebook
BioVersys on Facebook
YouTube
BioVersys on YouTube
Last Transaction
1/6/2023

Financing History

Date
Type
Amount
Venture Equity
$35,363,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Marc Gitzinger
  Marc Gitzinger LinkedIn Profile  Marc Gitzinger Twitter Account  Marc Gitzinger News  Marc Gitzinger on Facebook
Chief Financial Officer
Martin Bott
  Martin Bott LinkedIn Profile  Martin Bott Twitter Account  Martin Bott News  Martin Bott on Facebook
Chief Scientific Officer
Sergio Lociuro
  Sergio Lociuro LinkedIn Profile  Sergio Lociuro Twitter Account  Sergio Lociuro News  Sergio Lociuro on Facebook


Company Investors

 

 

 

Browse more funded tech companies:

BioVeritas | BioVex

 

Share this article

 


About Our VC & M&A Database

This tech company profile is powered by VentureDeal.com, a leading supplier of venture capital funding data.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary